Kidins220 accumulates with tau in human alzheimer's disease and related models: Modulation of its calpain-processing by GSK3β/PP1 imbalance

Human Molecular Genetics

Volumn 22, Issue 3, 2013, Pages 466-482

  López menéndez, Celia ^a,b   Gamir morralla, Andrea ^a,b   Jurado arjona, Jerónimo ^b,c   Higuero, Alonso M ^a,b,e   Campanero, Miguel R ^a   Ferrer, Isidro ^b,d   Hernández, Félix ^b,c   Ávila, Jesús ^b,c   Díaz Guerra, Margarita ^a   Iglesias, Teresa ^a,b  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e HOSPITAL NACIONAL DE PARAPLÉJICOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN 1; GLYCOGEN SYNTHASE KINASE 3BETA; KINASE D INTERACTING SUBSTRATE 220; KINESIN 1; MESSENGER RNA; NEUROTROPHIN; PHOSPHOPROTEIN PHOSPHATASE 1; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN ISCHEMIA; CHRONIC BRAIN DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DOWN REGULATION; EMBRYO; ENZYME ACTIVITY; EX VIVO STUDY; EXCITOTOXICITY; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NERVE DEGENERATION; NEUROMODULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STABILITY; RAT; SIGNAL TRANSDUCTION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIMALS; BRAIN ISCHEMIA; CALPAIN; CELL DEATH; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HEK293 CELLS; HUMANS; MALE; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NEURONS; OKADAIC ACID; PHOSPHORYLATION; PROTEIN PHOSPHATASE 1; PROTEOLYSIS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; TAU PROTEINS;

MUS MUSCULUS;

EID: 84872415076     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds446     Document Type: Article

References (81)

1. Querfurth, H.W. and LaFerla, F.M. (2010) Alzheimer's disease. N. Engl. J. Med., 362, 329-344.
2. Ballatore, C., Lee, V.M. and Trojanowski, J.Q. (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci., 8, 663-672.
3. Liu, R. and Wang, J.Z. (2009) Protein phosphatase 2A in Alzheimer's disease. Pathophysiology, 16, 273-277.
4. Takashima, A. (2006) GSK-3 is essential in the pathogenesis of Alzheimer's disease. J. Alzheimers Dis., 9, 309-317.
5. Hernandez, F. and Avila, J. (2008) The role of glycogen synthase kinase 3 in the early stages of Alzheimers' disease. FEBS Lett., 582, 3848-3854.
6. Hernandez, F., de Barreda, E.G., Fuster-Matanzo, A., Goni-Oliver, P., Lucas, J.J. and Avila, J. (2009) The role of GSK3 in Alzheimer disease. Brain Res. Bull., 80, 248-250.
7. Avila, J., Wandosell, F. and Hernandez, F. (2010) Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors. Expert. Rev. Neurother., 10, 703-710.
8. Medina, M. and Avila, J. (2011) Glycogen synthase kinase-3 (GSK-3) inhibitors for the treatment of Alzheimer's disease. Curr. Pharm. Des., 16, 2790-2798.
9. Hooper, C., Killick, R. and Lovestone, S. (2008) The GSK3 hypothesis of Alzheimer's disease. J. Neurochem., 104, 1433-1439.
10. Muyllaert, D., Kremer, A., Jaworski, T., Borghgraef, P., Devijver, H., Croes, S., Dewachter, I. and Van Leuven, F. (2008) Glycogen synthase kinase-3 beta, or a link between amyloid and tau pathology? Genes Brain Behav., 7, 57-66.
11. Hernandez, F., Gomez de Barreda, E., Fuster-Matanzo, A., Lucas, J.J. and Avila, J. (2010) GSK3: a possible link between beta amyloid peptide and tau protein. Exp. Neurol., 223, 322-325.
12. Terwel, D., Muyllaert, D., Dewachter, I., Borghgraef, P., Croes, S., Devijver, H. and Van Leuven, F. (2008) Amyloid activates GSK-3 beta to aggravate neuronal tauopathy in bigenic mice. Am. J. Pathol., 172, 786-798.
13. Choi, D.W. (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron, 1, 623-634.
14. Chohan, M.O. and Iqbal, K. (2006) From tau to toxicity: emerging roles of NMDA receptor in Alzheimer's disease. J. Alzheimers Dis., 10, 81-87.
15. Reisberg, B., Doody, R., Stoffler, A., Schmitt, F., Ferris, S. and Mobius, H.J. (2003) Memantine in moderate-to-severe Alzheimer's disease. N. Engl. J. Med., 348, 1333-1341.
16. Ittner, L.M. and Gotz, J. (2011) Amyloid-beta and tau: a toxic pas de deux in Alzheimer's disease. Nat. Rev. Neurosci., 12, 65-72.
17. Roberson, E.D., Scearce-Levie, K., Palop, J.J., Yan, F., Cheng, I.H., Wu, T., Gerstein, H., Yu, G.Q. and Mucke, L. (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science, 316, 750-754.
18. Ittner, L.M., Ke, Y.D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wolfing, H., Chieng, B.C., Christie, M.J., Napier, I.A. et al. (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell, 142, 387-397.
19. Bliss, T.V. and Collingridge, G.L. (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature, 361, 31-39.
20. Aamodt, S.M. and Constantine-Paton, M. (1999) The role of neural activity in synaptic development and its implications for adult brain function. Adv. Neurol., 79, 133-144.
21. Tezuka, T., Umemori, H., Akiyama, T., Nakanishi, S. and Yamamoto, T. (1999) PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A. Proc. Natl Acad. Sci. USA, 96, 435-440.
22. Miyamoto, Y., Chen, L., Sato, M., Sokabe, M., Nabeshima, T., Pawson, T., Sakai, R. and Mori, N. (2005) Hippocampal synaptic modulation by the phosphotyrosine adapter protein ShcC/N-Shc via interaction with the NMDA receptor. J. Neurosci., 25, 1826-1835.
23. Kaplan, D.R. and Miller, F.D. (2000) Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol., 10, 381-391.
24. Appel, S.H. (1981) A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease. Ann. Neurol., 10, 499-505.
25. Dawbarn, D. and Allen, S.J. (2003) Neurotrophins and neurodegeneration. Neuropathol. Appl. Neurobiol., 29, 211-230.
26. Salehi, A., Delcroix, J.D. and Mobley, W.C. (2003) Traffic at the intersection of neurotrophic factor signaling and neurodegeneration. Trends Neurosci., 26, 73-80.
27. Iglesias, T., Cabrera-Poch, N., Mitchell, M.P., Naven, T.J., Rozengurt, E. and Schiavo, G. (2000) Identification and cloning of Kidins220, a novel neuronal substrate of protein kinase D. J. Biol. Chem., 275, 40048-40056.
28. Kong, H., Boulter, J., Weber, J.L., Lai, C. and Chao, M.V. (2001) An evolutionarily conserved transmembrane protein that is a novel downstream target of neurotrophin and ephrin receptors. J. Neurosci., 21, 176-185.
29. Lopez-Menendez, C., Gascon, S., Sobrado, M., Vidaurre, O.G., Higuero, A.M., Rodriguez-Pena, A., Iglesias, T. and Diaz-Guerra, M. (2009) Kidins220/ARMS downregulation by excitotoxic activation of NMDARs reveals its involvement in neuronal survival and death pathways. J. Cell Sci., 122, 3554-3565.
30. Cabrera-Poch, N., Sanchez-Ruiloba, L., Rodriguez-Martinez, M. and Iglesias, T. (2004) Lipid raft disruption triggers protein kinase C and Src-dependent protein kinase D activation and Kidins220 phosphorylation in neuronal cells. J. Biol. Chem., 279, 28592-28602.
31. Sanchez-Ruiloba, L., Cabrera-Poch, N., Rodriguez-Martinez, M., Lopez-Menendez, C., Jean-Mairet, R.M., Higuero, A.M. and Iglesias, T. (2006) Protein kinase D intracellular localisation and activity control kinase D-interacting substrate of 220-kDa traffic through a postsynaptic density-95/discs large/zonula occludens-1-binding motif. J. Biol. Chem., 281, 18888-18900.
32. Arevalo, J.C., Yano, H., Teng, K.K. and Chao, M.V. (2004) A unique pathway for sustained neurotrophin signaling through an ankyrin-rich membrane-spanning protein. EMBO J., 23, 2358-2368.
33. Hisata, S., Sakisaka, T., Baba, T., Yamada, T., Aoki, K., Matsuda, M. and Takai, Y. (2007) Rap1-PDZ-GEF1 interacts with a neurotrophin receptor at late endosomes, leading to sustained activation of Rap1 and ERK and neurite outgrowth. J. Cell Biol., 178, 843-860.
34. Bracale, A., Cesca, F., Neubrand, V.E., Newsome, T.P., Way, M. and Schiavo, G. (2007) Kidins220/ARMS is transported by a kinesin-1-based mechanism likely to be involved in neuronal differentiation. Mol. Biol. Cell, 18, 142-152.
35. Neubrand, V.E., Thomas, C., Schmidt, S., Debant, A. and Schiavo, G. (2010) Kidins220/ARMS regulates Rac1-dependent neurite outgrowth by direct interaction with the RhoGEF Trio. J. Cell Sci., 123, 2111-2123.
36. Cesca, F., Yabe, A., Spencer-Dene, B., Arrigoni, A., Al-Qatari, M., Henderson, D., Phillips, H., Koltzenburg, M., Benfenati, F. and Schiavo, G. (2011) Kidins220/ARMS is an essential modulator of cardiovascular and nervous system development. Cell Death Dis., 2, e226.
37. Cesca, F., Yabe, A., Spencer-Dene, B., Scholz-Starke, J., Medrihan, L., Maden, C.H., Gerhardt, H., Orriss, I.R., Baldelli, P., Al-Qatari, M. et al. (2012) Kidins220/ARMS mediates the integration of the neurotrophin and VEGF pathways in the vascular and nervous systems. Cell Death Differ., 19, 194-208.
38. Higuero, A.M., Sanchez-Ruiloba, L., Doglio, L.E., Portillo, F., Abad-Rodriguez, J., Dotti, C.G. and Iglesias, T. (2010) Kidins220/ARMS modulates the activity of microtubule-regulating proteins and controls neuronal polarity and development. J. Biol. Chem., 285, 1343-1357.
39. Park, H.J., Park, H.W., Lee, S.J., Arevalo, J.C., Park, Y.S., Lee, S.P., Paik, K.S., Chao, M.V. and Chang, M.S. (2010) Ankyrin repeat-rich membrane spanning/Kidins220 protein interacts with mammalian Septin 5. Mol. Cells, 30, 143-148.
40. Alonso, A.D., Grundke-Iqbal, I., Barra, H.S. and Iqbal, K. (1997) Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc. Natl Acad. Sci. USA, 94, 298-303.
41. Ferreira, A. and Bigio, E.H. (2011) Calpain-mediated tau cleavage: a mechanism leading to neurodegeneration shared by multiple tauopathies. Mol. Med., 17, 676-685.
42. Higuchi, M., Iwata, N., Matsuba, Y., Takano, J., Suemoto, T., Maeda, J., Ji, B., Ono, M., Staufenbiel, M., Suhara, T. et al. (2012) Mechanistic involvement of the calpain-calpastatin system in Alzheimer neuropathology. FASEB J., 26, 1204-1217.
43. Sorimachi, Y., Harada, K. and Yoshida, K. (1996) Involvement of calpain in postmortem proteolysis in the rat brain. Forensic Sci. Int., 81, 165-174.
44. Litersky, J.M. and Johnson, G.V. (1992) Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain. J. Biol. Chem., 267, 1563-1568.
45. Yang, L.S. and Ksiezak-Reding, H. (1995) Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments. Eur. J. Biochem./FEBS, 233, 9-17.
46. Litersky, J.M., Johnson, G.V., Jakes, R., Goedert, M., Lee, M. and Seubert, P. (1996) Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356. Biochem. J., 316, 655-660.
47. Engel, T., Lucas, J.J., Gomez-Ramos, P., Moran, M.A., Avila, J. and Hernandez, F. (2006) Cooexpression of FTDP-17 tau and GSK-3 beta in transgenic mice induce tau polymerization and neurodegeneration. Neurobiol. Aging, 27, 1258-1268.
48. Liu, F., Li, B., Tung, E.J., Grundke-Iqbal, I., Iqbal, K. and Gong, C.X. (2007) Site-specific effects of tau phosphorylation on its microtubule assembly activity and self-aggregation. Eur. J. Neurosci., 26, 3429-3436.
49. Rankin, C.A., Sun, Q. and Gamblin, T.C. (2007) Tau phosphorylation by GSK-3 beta promotes tangle-like filament morphology. Mol. Neurodegener., 2, 12.
50. Jeganathan, S., Hascher, A., Chinnathambi, S., Biernat, J., Mandelkow, E.M. and Mandelkow, E. (2008) Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of Tau and generates a pathological (MC-1) conformation. J. Biol. Chem., 283, 32066-32076.
51. Kwok, J.B., Loy, C.T., Hamilton, G., Lau, E., Hallupp, M., Williams, J., Owen, M.J., Broe, G.A., Tang, N., Lam, L. et al. (2008) Glycogen synthase kinase-3 beta and tau genes interact in Alzheimer's disease. Ann. Neurol., 64, 446-454.
52. Yoon, S.Y., Choi, J.E., Yoon, J.H., Huh, J.W. and Kim, D.H. (2006) BACE inhibitor reduces APP-beta-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration. Neurobiol. Dis., 22, 435-444.
53. Morfini, G., Szebenyi, G., Elluru, R., Ratner, N. and Brady, S.T. (2002) Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J., 21, 281-293.
54. Szatmari, E., Habas, A., Yang, P., Zheng, J.J., Hagg, T. and Hetman, M. (2005) A positive feedback loop between glycogen synthase kinase 3 beta and protein phosphatase 1 after stimulation of NR2B NMDA receptors in forebrain neurons. J. Biol. Chem., 280, 37526-37535.
55. Lucas, J.J., Hernandez, F., Gomez-Ramos, P., Moran, M.A., Hen, R. and Avila, J. (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J., 20, 27-39.
56. Engel, T., Goni-Oliver, P., Gomez-Ramos, P., Moran, M.A., Lucas, J.J., Avila, J. and Hernandez, F. (2008) Hippocampal neuronal subpopulations are differentially affected in double transgenic mice overexpressing frontotemporal dementia and parkinsonism linked to chromosome 17 tau and glycogen synthase kinase-3 beta. Neuroscience, 157, 772-780.
57. Sutherland, C. (2011) What are the bona fide GSK3 substrates? Int. J. Alzheimers Dis., 2011, 505607.
58. Goedert, M. and Spillantini, M.G. (2000) Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease. Biochim. Biophys. Acta, 1502, 110-121.
59. Han, D. and Paudel, H.K. (2009) FTDP-17 missense mutations site-specifically inhibit as well as promote dephosphorylation of microtubule-associated protein tau by protein phosphatases of HEK-293 cell extract. Neurochem. Int., 54, 14-27.
60. Stokin, G.B., Lillo, C., Falzone, T.L., Brusch, R.G., Rockenstein, E., Mount, S.L., Raman, R., Davies, P., Masliah, E., Williams, D.S. et al. (2005) Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science, 307, 1282-1288.
61. Neubrand, V.E., Cesca, F., Benfenati, F. and Schiavo, G. (2012) Kidins220/ARMS as a functional mediator of multiple receptor signalling pathways. J. Cell Sci., 125, 1845-1854.
62. Utton, M.A., Noble, W.J., Hill, J.E., Anderton, B.H. and Hanger, D.P. (2005) Molecular motors implicated in the axonal transport of tau and alpha-synuclein. J. Cell Sci., 118, 4645-4654.
63. Cuchillo-Ibanez, I., Seereeram, A., Byers, H.L., Leung, K.Y., Ward, M.A., Anderton, B.H. and Hanger, D.P. (2008) Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin. FASEB J., 22, 3186-3195.
64. Perlson, E., Maday, S., Fu, M.M., Moughamian, A.J. and Holzbaur, E.L. (2010) Retrograde axonal transport: pathways to cell death? Trends Neurosci., 33, 335-344.
65. Rajendran, L. and Annaert, W. (2012) Membrane trafficking pathways in Alzheimer's disease. Traffic, 13, 759-770.
66. Tian, Q. and Wang, J. (2002) Role of serine/threonine protein phosphatase in Alzheimer's disease. Neuro-Signals, 11, 262-269.
67. Braak, E., Braak, H. and Mandelkow, E.M. (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol., 87, 554-567.
68. Liu, M.C., Kobeissy, F., Zheng, W., Zhang, Z., Hayes, R.L. and Wang, K.K. (2011) Dual vulnerability of tau to calpains and caspase-3 proteolysis under neurotoxic and neurodegenerative conditions. ASN Neuro., 3, e00051.
69. Gong, C.X., Singh, T.J., Grundke-Iqbal, I. and Iqbal, K. (1993) Phosphoprotein phosphatase activities in Alzheimer disease brain. J. Neurochem., 61, 921-927.
70. Vintem, A.P., Henriques, A.G., da Cruz, E.S.O.A. and da Cruz, E.S.E.F. (2009) PP1 inhibition by A beta peptide as a potential pathological mechanism in Alzheimer's disease. Neurotoxicol. Teratol., 31, 85-88.
71. Wang, J.Z., Gong, C.X., Zaidi, T., Grundke-Iqbal, I. and Iqbal, K. (1995) Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. J. Biol. Chem., 270, 4854-4860.
72. Johnson, G.V. (2006) Tau phosphorylation and proteolysis: insights and perspectives. J. Alzheimers Dis., 9, 243-250.
73. Carragher, N.O. (2006) Calpain inhibition: a therapeutic strategy targeting multiple disease states. Curr. Pharm. Des., 12, 615-638.
74. Sanchez, C., Arellano, J.I., Rodriguez-Sanchez, P., Avila, J., DeFelipe, J. and Diez-Guerra, F.J. (2001) Microtubule-associated protein 2 phosphorylation is decreased in the human epileptic temporal lobe cortex. Neuroscience, 107, 25-33.
75. Sanchez, S., Sayas, C.L., Lim, F., Diaz-Nido, J., Avila, J. and Wandosell, F. (2001) The inhibition of phosphatidylinositol-3-kinase induces neurite retraction and activates GSK3. J. Neurochem., 78, 468-481.
76. Santpere, G., Nieto, M., Puig, B. and Ferrer, I. (2006) Abnormal Sp1 transcription factor expression in Alzheimer disease and tauopathies. Neurosci. Lett., 397, 30-34.
77. Llorens-Martin, M., Torres-Aleman, I. and Trejo, J.L. (2006) Pronounced individual variation in the response to the stimulatory action of exercise on immature hippocampal neurons. Hippocampus, 16, 480-490.
78. Xue, Y., Ren, J., Gao, X., Jin, C., Wen, L. and Yao, X. (2008) GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy. Mol. Cell. Proteomics, 7, 1598-1608.
79. Blom, N., Sicheritz-Ponten, T., Gupta, R., Gammeltoft, S. and Brunak, S. (2004) Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics, 4, 1633-1649.
80. Gnad, F., Ren, S., Cox, J., Olsen, J.V., Macek, B., Oroshi, M. and Mann, M. (2007) PHOSIDA (phosphorylation site database): management, structural and evolutionary investigation, and prediction of phosphosites. Genome Biol., 8, R250.
81. Dinkel, H., Michael, S., Weatheritt, R.J., Davey, N.E., Van Roey, K., Altenberg, B., Toedt, G., Uyar, B., Seiler, M., Budd, A. et al. (2012) ELM: the database of eukaryotic linear motifs. Nucleic Acids Res., 40, D242-D251.